<?xml version='1.0' encoding='utf-8'?>
<?xml-stylesheet type="text/xsl" href="/v2/static/oai2.xsl"?>
<OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2026-10-14T05:51:19Z</responseDate>
  <request identifier="oai:figshare.com:article/33794215" metadataPrefix="oai_dc" verb="GetRecord">https://api.figshare.com/v2/oai</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:figshare.com:article/33794215</identifier>
        <datestamp>2026-09-15T12:57:29Z</datestamp>
        <setSpec>category_363</setSpec>
        <setSpec>portal_316</setSpec>
        <setSpec>item_type_3</setSpec>
        <setSpec>month_year_09_2026</setSpec>
      </header>
      <metadata>
        <oai_dc:dc xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"  xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
          <dc:title>Table 1_Gray matter atrophy mediates the association between cerebral hypometabolism and cognitive impairment in Alzheimer’s disease.docx</dc:title>
          <dc:creator>Shiqi Zhao (5939993)</dc:creator>
          <dc:creator>Jianwen Chen (2211184)</dc:creator>
          <dc:creator>Peixue Li (611960)</dc:creator>
          <dc:creator>Li Zhao (147498)</dc:creator>
          <dc:creator>Chunbo Dong (728665)</dc:creator>
          <dc:creator>Lei Yu (70258)</dc:creator>
          <dc:subject>Neurology and Neuromuscular Diseases</dc:subject>
          <dc:subject>Alzheimer’s disease</dc:subject>
          <dc:subject>amyloid-β</dc:subject>
          <dc:subject>APoE ε4</dc:subject>
          <dc:subject>FDG-PET</dc:subject>
          <dc:subject>gray matter atrophy</dc:subject>
          <dc:subject>multimodal imaging</dc:subject>
          <dc:description>Objective&lt;p&gt;Alzheimer’s disease (AD) is characterized by amyloid deposition, brain hypometabolism, gray matter atrophy and cognitive decline, yet their causal interactions are poorly defined. This multimodal PET/MRI study explored regional gray matter volume (GMV) loss and glucose hypometabolism in AD patients, and clarified their correlations with distinct cognitive deficits alongside mediating pathways.&lt;/p&gt;Methods&lt;p&gt;134 probable dementia patients were split into AD and non-AD dementia cohorts based on &lt;sup&gt;18&lt;/sup&gt;F-AV45 PET amyloid-β (Aβ) load, all receiving structural MRI, &lt;sup&gt;18&lt;/sup&gt;F-FDG and &lt;sup&gt;18&lt;/sup&gt;F-AV45 PET scans. We compared intergroup GMV and metabolic discrepancies, analyzed imaging-cognition correlations adjusted for clinical and demographic confounders, and implemented mediation models to test whether GMV bridges cerebral metabolism and cognition.&lt;/p&gt;Results&lt;p&gt;AD patients exhibited prominent regional GMV shrinkage and FDG hypometabolism in vulnerable brain regions relative to non-AD dementia subjects. Covariate-adjusted analyses linked both imaging biomarkers to domain-specific cognitive performance. Primary mediation analyses showed that regional GMV significantly mediated the associations between FDG metabolism and visuospatial, executive, and language function, accounting for 40.36, 35.60, and 49.99% of the total effects, respectively. Reverse mediation models identified only a weak indirect effect of right superior temporal gyrus metabolism on the association between right inferior parietal lobule GMV and visuospatial ability, accounting for 13.26% of the total effect. Moreover, after multiple-imputation sensitivity analyses, most indirect effects became unstable or nonsignificant, suggesting that the FDG metabolism–cognition association is predominantly direct, with limited evidence for GMV mediation.&lt;/p&gt;Conclusion&lt;p&gt;Integrated PET/MRI revealed AD-related patterns of regional atrophy and hypometabolism. Overall, the association between cerebral metabolic dysfunction and cognitive impairment appeared to be predominantly direct, with limited evidence supporting a mediating role of regional GMV.&lt;/p&gt;</dc:description>
          <dc:date>2026-09-15T12:57:29Z</dc:date>
          <dc:type>Dataset</dc:type>
          <dc:type>Dataset</dc:type>
          <dc:identifier>10.3389/fneur.2026.1919778.s001</dc:identifier>
          <dc:relation>https://figshare.com/articles/dataset/Table_1_Gray_matter_atrophy_mediates_the_association_between_cerebral_hypometabolism_and_cognitive_impairment_in_Alzheimer_s_disease_docx/33794215</dc:relation>
          <dc:rights>CC BY 4.0</dc:rights>
        </oai_dc:dc>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
